Study results indicate BAX326 shows potential and is an efficacious and safe alternative treatment for patients with hemophilia B.
August 2014
Patients on FVIII therapies may develop antibodies that diminish treatment efficacy, may not be able to handle frequent dosing schedules, and may not be able to afford the cost of treatment.
Advertisement
Advertisement
Trending on HCPLive
1
Navigating Emotional Burden in IBD
2
Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD
3
Open Communication Between Patients and Providers in IBD
4
Linaclotide in Pediatric IBS-C—Evidence, Indications, and Practical Use
5